Analyzing Rennova Health (OTCMKTS:RNVA) & HeartSciences (NASDAQ:HSCS)

Rennova Health (OTCMKTS:RNVA) and HeartSciences (NASDAQ:HSCS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, valuation, risk and dividends.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Rennova Health and HeartSciences, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rennova Health	0	0	0	0	0.00
HeartSciences	1	0	1	0	2.00

HeartSciences has a consensus target price of $8.00, indicating a potential upside of 290.24%. Given HeartSciences’ stronger consensus rating and higher probable upside, analysts plainly believe HeartSciences is more favorable than Rennova Health.

Risk & Volatility

Rennova Health has a beta of 23.78, indicating that its share price is 2,278% more volatile than the S&P 500. Comparatively, HeartSciences has a beta of 2.44, indicating that its share price is 144% more volatile than the S&P 500.

Institutional and Insider Ownership

17.2% of HeartSciences shares are owned by institutional investors. 55.5% of Rennova Health shares are owned by insiders. Comparatively, 4.9% of HeartSciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Rennova Health and HeartSciences”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rennova Health	$18.69 million	0.00	-$7.73 million	N/A	N/A
HeartSciences	N/A	N/A	-$8.77 million	($4.94)	-0.41

Rennova Health has higher revenue and earnings than HeartSciences.

Profitability

This table compares Rennova Health and HeartSciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Rennova Health	N/A	N/A	N/A
HeartSciences	N/A	-333.50%	-140.18%

Summary

Rennova Health beats HeartSciences on 6 of the 10 factors compared between the two stocks.

About Rennova Health

Rennova Health, Inc., together with its subsidiaries, provides health care services in the United States. It owns one operating hospital in Oneida, Tennessee; and a rural clinic in Williamsburg, Kentucky. The company is based in West Palm Beach, Florida.

About HeartSciences

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.